Effects of microcystin-LR exposure on matrix metalloproteinase-2/-9 expression and cancer cell migration

Zongyao Zhang1, Xu-Xiang Zhang, Wendi Qin

  • 1State Key Laboratory of Pollution Control and Resource Reuse, School of the Environment, Nanjing University, Nanjing 210046, China.

Insights

Chronic exposure to microcystin-LR (MC-LR) increases matrix metalloproteinases (MMPs) in the liver and stimulates cancer cell migration. This study highlights potential risks associated with MC-LR contamination.

Area of Science:

  • Environmental toxicology
  • Molecular biology
  • Cancer research

Background:

  • Microcystin-LR (MC-LR) is a common cyanotoxin with potential health impacts.
  • Matrix metalloproteinases (MMPs) are enzymes involved in tissue remodeling and cancer progression.
  • Understanding MC-LR's effects on MMPs and cell migration is crucial for risk assessment.

Purpose of the Study:

  • To investigate the impact of chronic MC-LR exposure on hepatic MMP expression.
  • To determine MC-LR's effect on the migration of breast cancer cells.
  • To elucidate the relationship between MC-LR, MMPs, and cancer cell motility.

Main Methods:

  • Oral administration of MC-LR to male mice for 270 days.
  • Histopathological examination of liver tissues.
  • Immunohistochemical staining, ELISA, and quantitative RT-PCR for MMP-2/-9 expression analysis.
  • In vitro culture of MDA-MB-435s breast cancer cells with MC-LR and wound healing assays.

Main Results:

  • MC-LR exposure led to hepatic lymphocyte infiltration and fatty degeneration in mice.
  • MC-LR significantly up-regulated hepatic MMP-2/-9 expression and mRNA levels.
  • MC-LR exposure stimulated breast cancer cell migration in a time- and dose-dependent manner.
  • Increased cellular MMP-2/-9 expression was observed in MC-LR-treated cancer cells.

Conclusions:

  • Chronic MC-LR exposure alters hepatic MMP-2/-9 expression.
  • MC-LR can stimulate cancer cell migration, potentially through MMP modulation.
  • These findings suggest a potential mechanism for MC-LR's role in cancer progression.